VivoSim Labs, Inc.

Stage 4 · Declining · week 46

As of Oct 22, 2026, VivoSim Labs is in Stage 4, the downtrend phase, now in week 46 (since Nov 28, 2025). It closed at $0.16, 94.6% below its 52-week high and below its 200-day average, which is falling.

$0.16

-11.11% today

$2.6M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is VIVS early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 18w

S4 41w

S4 18w

S4 47w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S4 13w → S1 4w → S4 18w → S1 4w → S4 41w → S1 4w → S4 18w → S1 13w → S2 3w → S3 1w → S4 47w current

Total tracked: 166 weeks across 11 stage runs.

VIVS among Biotechnology518th of 591 by relative strength

All 591 →

Stocks in Biotechnology ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	GTBPGT Biopharma, Inc.	Stage 2 · wk 7	99	−22.3%
2	IOVAIovance Biotherapeutics, Inc.	Stage 2 · wk 18	99	+38.8%
3	SLSSELLAS Life Sciences Group, Inc.	Stage 3 · wk 4	99	−1.5%
4	MRNAModerna, Inc.	Stage 2 · wk 17	99	+11.3%
5	TWSTTwist Bioscience Corporation	Stage 2 · wk 39	99	−14.5%
6	KODKodiak Sciences Inc	Stage 2 · wk 4	99	+172.1%
7	ERASErasca, Inc.	Stage 3 · wk 5	99	+0.7%
8	CLYMClimb Bio, Inc.	Stage 3 · wk 3	99	−15.8%
…518	VIVSVivoSim Labs, Inc.	Stage 4 · wk 46	6	−30.4%

vs 52W High

-94.6%

$0.16 lo$2.98 hi

94.6% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 46

1w13w26w

Week 46, extended decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-85.8%

200 DMA: $1.13 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

2.72x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-30.4%

-61.9%

-89.2%

YTD

-91.5%

-93.6%

Scan Membership

Breakout Watch

Latest: 2023-04-03

3 appearances in last 60 days. First seen: 2020-05-14.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 46 · Vol 2.72x

2026-10-21S4

Wk 45 · Vol 2.74x

2026-10-20S4

Wk 45 · Vol 0.64x

2026-10-19S4

Wk 45 · Vol 0.12x

2026-10-16S4

Wk 45 · Vol 0.27x

2026-10-15S4

Wk 45 · Vol 1.16x

2026-10-14S4

Wk 44 · Vol 0.12x

2026-10-13S4

Wk 44 · Vol 0.06x

2026-10-12S4

Wk 44 · Vol 0.34x

2026-10-09S4

Wk 44 · Vol 0.10x

2026-10-08S4

Wk 44 · Vol 0.26x

2026-10-07S4

Wk 43 · Vol 0.27x

Moving averages & range

50 DMA

$0.24

200 DMA

$1.13

52W High

$2.98

52W Low

$0.16

5D Low

$0.16

Resistance levels (recent highs)

20d High

$0.22

60d High

$0.47

120d High

$1.42

250d High

$2.98

Next resistance

+37.5%

to 20d High

ROE

-343.1%

Profit margin 0.0%

Dividend Yield

0.00%

P/B -0.2

VivoSim Labs: quick answers

What stage is VivoSim Labs in?

As of Oct 22, 2026, VivoSim Labs (VIVS) is in Stage 4, the downtrend phase. It entered Stage 4 on Nov 28, 2025 and is in week 46. What the four stages mean

Is VivoSim Labs in an uptrend?

No. VivoSim Labs is in a Stage 4 downtrend. It trades 85.8% below its 200-day average, which is falling.

How far is VivoSim Labs from its 52-week high?

VivoSim Labs closed at $0.16 on Oct 22, 2026, 94.6% below its 52-week high of $2.98. Its 52-week low is $0.16.

How has VivoSim Labs performed over the past year?

As of Oct 22, 2026, VivoSim Labs is down 93.6% over the past year and down 91.5% so far in 2026.

Which sector and industry is VivoSim Labs in?

VivoSim Labs is in the Biotechnology industry, part of the Health Care sector.

About this companyHealth Care· Biotechnology

VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at various stages of drug development; and build functional 3D human tissues through its proprietary technologies that mimic key aspects of native human tissue composition, architecture, function, and disease. In addition, it offers 3D human tissue platform that develops novel human normal and disease models using high throughput systems, bioprinted, and flow/stretch capable 3D systems. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. VivoSim Labs, Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.